Profile

Biography

Anne has worked at the Centre for Health Economics since 1998, and been a member of the Health Policy Team since 2006.  Her principal interest is the role of economic incentives in influencing provider behaviour.  She is the ethics lead for CHE and deputy team leader of the Health Policy team.

Current research includes an evaluation of the effects of GP care on emergency admissions for people with serious mental illness (HS&DR Project - 10/1011/22).  Anne has contributed to several Technology Assessment reports commissioned by the HTA programme on behalf of NICE and worked on the ‘EuroDRG’ project, which was  funded under the 7th EU Framework Programme.  Other research includes evaluating healthcare payment systems; assessing treatments for psoriasis; incentives and governance in public health; and access to anticancer drugs.  She is the author of four books and over 35 scientific papers.

Anne is married and has four adult children.  In her spare time, she enjoys walking in the local countryside.

Research

Overview

• the role of economic incentives in influencing provider behaviour
• payment systems in mental health, acute care and primary care
• access to anticancer drugs
• topical treatments for chronic plaque psoriasis
• respite care for frail older people
• use and construction of Diagnosis Related Groups
• effects of GP care for people with serious mental illness on emergency admissions
  

Research group(s)

• Health Policy Team 
  

Publications

Full publications list

2013

• Marks L, Weatherly HLA, Mason A. Prioritizing investment in public health and health equity: what can commissioners do? Public Health 2013;doi.org/10.1016/j.puhe.2013.01.027.
• Mason A, Mason JM, Cork M, Hancock H, Dooley G. Topical Treatments for chronic plaque psoriasis of the scalp: a systematic review. British Journal of Dermatology 2013. In press.
• Mason A, Mason J, Cork M, Dooley G, Hancock H. Topical treatments for chronic plaque psoriasis. Cochrane database of systematic reviews (Online). 2013 Mar 28;(3)Art.No.:CD005028.
• Pattenden J, Mason A, Lewin B. Collaborative palliative care for advanced heart failure: outcomes and costs from the 'Better
  Together' pilot study. BMJ Supportive and Palliative Care. 2013;3(1):69-76. 

2012

• Gaughan J, Kobel C, Linhart C, Mason A, Street A, Ward P. Why do patients having coronary artery bypass grafts have different costs or length of stay? An analysis across ten European countries. Health Economics 2012;21(S2):77-88. Download from wiley
• Gaughan J, Mason A, Street A, Ward P. English hospitals can improve their use of resources: an analysis of costs and length of stay for ten treatments: Centre for Health Economics, University of York;CHE Research Paper 78 (PDF , 1,697kb) 2012.
• Mason A, Or Z, Renaud T, Street A, Thuilliez J, Ward P. How well do DRGs for appendectomy explain variations in resource use? An analysis of patient-level data from 10 European countries. Health Economics 2012;21(S2):30-40. Download from wiley

2011

• Garau M, Shah K, Mason A, Wang Q, Towse A, Drummond M. Using QALYs in cancer: a review of the methodological limitations. Pharmacoeconomics 2011;29(8):673-85.
• Marks L, Cave S, Wallace A, Mason A, Hunter DJ, Mason JM, Peckham S. Incentivising preventive services in primary care: perspectives on the use of Local Enhanced Services. Journal of Public Health 2011; 33 (4): 556-564.
• Mason A, Goddard M, Myers L, Verzulli R. Navigating uncharted waters? How international experience can inform the funding of mental health care in England. Journal of Mental Health 2011;20(3);234-48.
• Mason A, Ward P, Street A. England: the Healthcare Resource Group system. In: Busse R, Geissler A, Quentin W, Wiley M, editors. Diagnosis related groups in Europe: moving towards transparency, efficiency and quality in hospitals. Berkshire, England: Open University Press;2011;p197-220.
• Street A, O'Reilly J, Ward P, Mason A. DRG-based hospital payment and efficiency: theory, evidence, and challenges. In: Busse R, Geissler A, Quentin W, Wiley M, editors. Diagnosis Related Groups in Europe: moving towards transparency, efficiency and quality in hospitals. Berkshire, England:Open University Press;2011:p93-114.

2010

• Marks L, Cave S, Hunter DJ, Mason JM, Peckham S, Wallace A, Mason A, Weatherly H, Melvin K. Public health governance and primary care delivery: a triangulated study. final report; NIHR Service Delivery and Organisation programme 2010. Full Report and Executive Summary
• Mason A. Hospital car parking: the impact of access costs. Centre for Health Economics, University of York; CHE Research Paper 59 (PDF , 1,756kb), 2010.
• Mason A, Drummond M, Ramsey S, Campbell J, Raisch D. Comparison of anticancer drug coverage decisions in the United States and United Kingdom: does the evidence support the rhetoric? Journal of Clinical Oncology 2010;28(20):3234-38.
• Mason A, Street A, Verzulli R. Private sector treatment centres are treating less complex patients than the NHS. Journal of the Royal Society of Medicine 2010;103:322-31.
• Pattenden J, Mason A. Better Together: An end of life initiative for patients with heart failure and their families. M123S: Executive summary. British Heart Foundation, London. June 2010. Download from BHF
• Pattenden J, Mason A. Better Together: An end of life initiative for patients with heart failure and their families. M123R: Final Report. British Heart Foundation, London. June 2010. Download from BHF
• Street A, Sivey P, Mason A, Miraldo M, Siciliani L. Are English treatment centres treating less complex patients? Health Policy 2010; 94(2): 150-157.
• Walker S, Mason A, Claxton K, Cookson R, Fenwick E, Fleetcroft R, Sculpher M. Value for money and the quality and outcomes framework in primary care in the NHS. British Journal of General Practice 2010;60(574):213-20. Download from Ingentaconnect
• Weatherly H, Mason A, Goddard M, Wright K Financial integration across health and social care: evidence review.  Scottish Government Social Research, Crown Copyright 2010.  http://www.scotland.gov.uk/Resource/Doc/303234/0095107.pdf
• Weatherly H, Mason A, Goddard M, Wright K. Financial integration across health and social care: evidence review. Research Findings No.95/2010. http://www.scotland.gov.uk/Resource/Doc/303229/0095106.pdf 

2009

• Drummond M, Mason A. Rationing new medicines in the UK: A fair and consistent process is needed for dealing with absence of evidence (invited editorial)  BMJ. 2009;338:a3182.Download from BMJ
• Mason AR, Drummond M. Public funding of new cancer drugs: is NICE getting nastier? European Journal of Cancer. 2009;45(7):1188-92.
• Mason A, Goddard M. Payment by results in mental health: a review of the international literature and an economic assessment of the approach in the English NHS. Centre for Health Economics, University of York; CHE Research Paper 50 (PDF , 566kb), 2009.
• Mason AR, Mason J, Cork M, Dooley G, Edwards G. Topical treatments for chronic plaque psoriasis. Cochrane Database of Systematic Reviews 2009. Issue 2. Art. No.: CD005028. DOI: 10.1002/14651858.CD005028.pub2.ISSN 1465-780X. Download from Cochrane and  Podcast available from Cochrane
• Mason A, Street A, Miraldo M, Siciliani L. Should prospective payments be differentiated for public and private healthcare providers? Health Economics, Policy and Law. 2009;4(4):383-403. Should prospective payments be differentiated (PDF , 124kb)
• Goddard M, Mason A. Mental health learning points. Healthcare Finance. 2009 (November);pp39,41.

2008

• Mason A, Carr-Hill R, Myers L, Street A. Establishing the economics of engaging communities in health promotion: what is desirable, what is feasible? Critical Public Health. 2008;18(3):285-97.
• Chauhan D, Mason A. Factors affecting the uptake of new medicines in secondary care - a literature review. Journal of Clinical Pharmacy and Therapeutics. 2008;33(4):339-48.
• Mason A, Miraldo M, Siciliani L, Sivey P, Street A. Establishing a fair playing field for payment by results. Centre for Health Economics, University of York; CHE Research Paper 39 (PDF , 1,178kb), 2008.
• Mason A, Walker S, Claxton K, Cookson R, Fenwick E, Sculpher M. The GMS quality and outcomes framework: Are the quality and outcomes framework (QOF) indicators a cost-effective use of NHS resources? In: Quality and outcomes framework. Joint executive summary: Reports to the Department of Health from the University of East Anglia and the University of York. The GMS quality and outcomes framework (PDF , 238kb)
• Mason AR, Drummond M. NHS Reimbursement of new cancer drugs: is NICE getting nastier? (abstract from the ISPOR thirteenth annual international meeting May 3-7 2008). Value in Health. 2008;11(3):A11.
• Golder S, Mason A, Spilsbury K. Systematic searches for the effectiveness of respite care. Journal of the Medical Library Association. 2008;96(2):147-52.
• Epstein D, Mason A, Manca A. The hospital costs of care for stroke in nine European countries. Health Economics. 2008;17 (S1):S21-S31. Download from Wiley Inter Science
• Mason A. New medicines in primary care: a review of influences on general practitioner prescribing. Journal of Clinical Pharmacy and Therapeutics. 2008;33(1):1-10.

2007

• Drummond M, Mason A. European perspective on the costs and cost-effectiveness of cancer therapies. Journal of Clinical Oncology. 2007;25(2):191-5.
• Drummond MF, Mason AR. In reply (letter responding to Low E. Many new cancer drugs in the United Kingdom are facing negative NICE rulings. Journal of Clinical Oncology 2007;25(18):2635-2636.). Journal of Clinical Oncology 2007;25(18):2637-2638. http://jco.ascopubs.org/cgi/reprint/25/18/2637
• Mason A. The HealthBASKET Project: documenting the benefit basket and evaluating service costs in Europe. In: Curtis L, ed. Unit Costs of Health and Social Care 2007. Canterbury: University of Kent 2007:15-18. http://www.pssru.ac.uk/pdf/uc/uc2007/uc2007_healthbasket.pdf
• Mason A, Towse A (eds). The ideas and influence of Alan Williams. Be reasonable - do it my way! New York: Radcliffe Publishing, Oxford. November 2007.

 

The ideas and influence of Alan Williams

• Authors:
  Anne Mason
  Adrian Towse
• Publisher:
  Radcliffe Publishing
• more information and ordering

• Mason A, Weatherly H, Spilsbury K, Golder S, Arksey H, Adamson J, et al. The effectiveness and cost-effectiveness of respite for caregivers of frail older people: a systematic review. J Am Geriatr Soc. 2007;55(2):290-9.
• Mason A, Weatherly H, Spilsbury K, Golder S, Arksey H, Adamson J, et al. A systematic review of the effectiveness and cost-effectiveness of different models of community-based care for frail older people and their carers. Health Technology Assessment ; April 2007;11(15):1-176. http//:www.hta.ac.uk/fullmono/mon1115.pdf

2006

• Mason A, Street A. Publishing outcomes data: is it an effective approach? Journal of Evaluation in Clinical Practice 2006;12(1):37-48.
• Drummond M, Mason A, Towse A. The desirability and feasibility of economic studies post-launch. European Journal of Health Economics 2006;1(7):5-6.
• Epstein D, Mason A. Costs and prices for inpatient care in England: mirror twins or distant cousins?  Health Care Management Science 2006;9(3):233-242.
• Mason A, Drummond M, Towse A. Economic post-launch studies: matching the desirable with the feasible. London: Office of Health Economics; 2006 September.
• Mason A, Smith PC.  Regulation and relations between the different participants in the English health care system.  Revue Française des Affaires Sociales. 2006;2:265-284.
• Mason J, Mason A.  The generalisability of pharmacoeconomic studies: issues and challenges ahead. Pharmacoeconomics 2006; 24(10): 937-945.
• Woolacott N, Hawkins N, Mason A, Kainth A, Khadjesari Z, Bravo Vergel Y, Misso K, Light K, Chalmers R,Sculpher M, Riemsma R. Etanercept and Efalizumab for the treatment of psoriasis: a systematic review. Health Technology  Assessment 2006;10(46):1-252. http://www.hta.ac.uk/fullmono/mon1046.pdf

2005

• Cooke J, Mason A, Drummond MF, Towse AK. Medication management in English National Health Service hospitals. American Journal of Health-System Pharmacy 2005;62:189-195.
• Mason A, Smith PC. Description of the Benefit Catalogue. Centre for Health Economics, University of York; CHE Research Paper 2 (PDF , 521kb) 2005.
• Mason A. Does the English NHS have a 'Health Basket'? European Journal of Health Economics 2005;6(1):SS18-23.
• Mason A, Drummond M, Hunter J, Towse A, Cooke J. An evaluation of prescribing incentive schemes: can they encourage cost-effective prescribing? Applied Health Economics and Health Policy 2005;5(2): 111-117.
• Mason A, Street A. To publish or not? Experience and evidence about publishing hospital outcomes data: London: Office of Health Economics; 2005.
• Wilby J, Kainth A, Hawkins N, Epstein D, McIntosh H, McDaid C, Mason A, Golder S, O'Meara S, Sculpher M, Drummond M, Forbes C. A rapid and systematic review of the clinical effectiveness, tolerability and cost effectiveness of newer drugs for epilepsy in adults. Health Technology Assessment 2005;9(15):1-172. http://www.hta.ac.uk/fullmono/mon915.pdf

External activities

Memberships

• NIHR Health Services and Delivery Research Board
  2013-2016 board member
• NIHR Health Services and Delivery Research Board
  2010-2012 associate board member
   

Invited talks and conferences

Primary Care Mental Health Conference, University of Manchester, 20 March 2013

• Is higher primary care quality associated with lower hospital admissions for people with severe mental illness?

European Conference on Health Economics Zurich, 18-21 July 2012

• Lessons learnt from the EuroDRG project (preconference workshop): DRGs for appendectomy
• The good, the bad and the ugly: investigating variations in efficiency in hospitals in the English NHS 

9th Evidence Based Update Meeting: Psoriasis, Holywell Park, Loughborough, 12-May 2011

• Topical Treatments for Chronic Plaque Psoriasis: an update

 European Conference on Health Economics Helsinki, 7-10 July 2010 

• Why do hospital costs vary? An evaluation of hospital efficiency and quality of care in England using Diagnosis Related Groups (DRGs)
• Integrated Resource Mechanisms within Health Care & across Health & Social Care: Evidence from the International Literature
• DRGs and hospital efficiency: Panacea or pitfall? 

Health Economic Study Group Meeting, Cork, 23-25 June 2010 

• Hospital Funding and Efficiency: Evidence on DRG-based reimbursement 

Commissioning for Health and Well Being: Policy into Practice, Durham, 31 March 2010 

• Prioritising Investment in Health and Wellbeing: Overview of Tools and their Relevance for Commissioners 

ISPOR 12th Annual European Congress, Paris, 24 - 27 October 2009

•  Is NICE Too Nasty? A comparison of anticancer drug coverage decisions in the United States and United Kingdom 

Cochrane Skin Group 12th Annual Meeting, London, 13-14 June 2008 

• Topical Treatments for Chronic Plaque Psoriasis: a systematic review 

ISPOR 13th Annual International Meeting, Toronto, May 3-7 2008 

• NHS Reimbursement of New Cancer Drugs: is NICE getting nastier?